
Photys Therapeutics
A proprietary chimeric small molecules platform company, developing a new class of medicines for precise control of protein function.
Employees
Enterprise value
$300—450m
Authorizing premium user...
A proprietary chimeric small molecules platform company, developing a new class of medicines for precise control of protein function.